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In most studies on the phenomenon of immunological tolerance as it applies to the 
cellular antigens responsible for transplantation immunity, neonatal mice or rats are 
inoculated  with  suspensions  of living, allogeneic cells and,  when  immunologically 
mature,  challenged  with  skin  allografts of the  same  genetic origin  as  the  putative 
tolerance-conferring stimulus.  If such  grafts are accepted permanently,  the animals 
are judged to be highly or completely tolerant, whereas if the grafts outlive those on 
untreated recipients but are eventually rejected, the hosts are considered partially or 
incompletely tolerant. Although there is evidence that exposure to the test graft may 
sometimes  augment  the  degree  of  unresponsiveness  induced  at birth  (1),  it  has 
generally been assumed that such grafts are indicators of, rather than contributors to, 
the immunological states of their hosts. We here provide evidence that this assumption 
is incorrect. Our results indicate that  the attributes of the test grafts that putatively 
tolerant rats are challenged with influence their immune response. Our findings also 
indicate that  the  survivals of these  grafts  are  determined  by the  same  factors  that 
operate when only weak histoincompatibilities prevail. 
Materials  and  Methods 
Rats.  Major  histocompatibility complex  (MHC)-incompatible  BN/Ss  (BN;  RTI")  and 
Lewis/Ss  (Lew;  RT11)  rats, as well as their F1  hybrids  (Lew/BN),  were  used.  The  median 
survival time (MST) of BN (or Lew/BN) skin on adult Lew hosts is ~ 10 d  (1). 
Because  there  was  no  difference  in  the  ability of bone  marrow  cells  from  reciprocally 
produced F1 hybrids to induce tolerance of skin, or of skin from these hybrids to survive on 
tolerant hosts, the results using them have been pooled. There also was no evidence of a  sex 
difference in tolerance susceptibility. Hence, the results with males and females have likewise 
been pooled. 
Tolerance Induction.  Tolerance was induced by inoculating rats <20 h old intravenously with 
suspensions of  bone marrow cells prepared from adult F1 hybrid animals according to procedures 
described elsewhere (2). 
Skin  Grafting.  Animals were grafted when  2 mo old. Grafting entailed the transfer of full- 
thickness ventral-trunk skin. The preparation of the grafts, as well as the operative technique, 
have been described elsewhere (3).  First grafts were always transplanted to the right thorax, 
and second grafts to the left. When animals were grafted simultaneously with two grafts of 
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different  sizes and/or origins,  their  positions on the  right  and  left  sides  of the thorax  were 
alternated. 
Grafts of two size ranges were used.  "Small" grafts were carefully prepared to measure 1 cm  ~ 
and  "large"  grafts  were  initially  6.25  cm  2 (2.5  X  2.5). However,  when  these  grafts  were 
remeasured at primary inspection  (9 d post-grafting) to assess more accurately their size, the 
small  grafts varied  from 0.75  to  1.5  cm  2 and  the  large  grafts  from 4.0  to  6.25  cm  2.  H-Y- 
incompatible  grafts were  avoided.  A  survival  time  of 100  d  was adopted  as  a  criterion  of 
permanent survival. In experiments in which putatively tolerant rats were each challenged with 
a single graft, litters were "split," with half receiving BN and the remainder receiving Lew/BN 
skin. 
MST.  The  MST  of grafts  were  determined  using  a  computer  program  using  probit 
transformation (4). 
Results 
Influence  of  Graft  Origin  and  Size  on  Survival  on  Putatively  Tolerant  Hosts.  These 
experiments were initiated  when, in the course of producing tolerant rats for another 
study,  we  obtained  a  considerably  higher  percentage  of "highly  tolerant"  animals 
than  anticipated  on the  basis  of prior results  (1,  5-7).  In trying to account  for this 
success, it occurred to us that our previous protocol for assessing tolerance had been 
modified.  Instead of challenging Lew rats with BN skin, they were test  grafted with 
Lew/BN  skin.  Moreover,  the  size  of the  grafts  was  considerably  larger  than  those 
previously used. To determine whether either or both of these factors were responsible 
for the discrepancy, Lew rats were injected at birth with  10, 20, or 100 ×  106 Lew/BN 
bone marrow cells  and,  when  mature,  challenged  with  either  large or small  BN or 
Lew/BN skin grafts. The results  (Table I) clearly indicate that the origin and size of 
the grafts play a  major role in determining their survival.  Large Lew/BN grafts are 
the most readily, and small BN grafts the least  likely, to be accepted. 
The influence that gene dosage has on graft survival is best exemplified by the fate 
of small grafts on rats inoculated at birth with  100 X  106 cells and by the survival of 
large grafts on 20  X  106 cell  recipients.  At  the  higher  dosage,  14 of 17  (82%)  small 
Lew/BN grafts survived for >100 d, whereas all  16 small BN grafts were rejected; at 
the lower dosage,  12 of 18  (67%)  large Lew/BN grafts but only 3/19  (16%)  similarly 
sized BN grafts survived for >100 d  (P <  0.01). Indeed, at every dosage at which the 
survivals of large and small Lew/BN and BN grafts were compared, the hybrid grafts 
did better. 
As inferred from the above results,  the size of the graft also plays a significant role 
in determining its survival on putatively tolerant hosts. In fact, graft size seems to be 
as important  a  factor as gene dosage. This is illustrated  by the survivals of large and 
small BN grafts on Lew recipients of 100 ×  106 cells. Whereas  14 of 20 (70%) large BN 
grafts were retained  in perfect condition for >100 d  on such recipients  (and 5 of the 
grafts that  were scored as rejected  nevertheless  persisted,  although  they were recog- 
nized only by the persistence of a  few pigmented hairs),  as noted above, all  16 small 
BN  grafts  were  rejected.  It  is  also  exemplified  by  the  survivals  of large  and  small 
Lew/BN grafts on Lew recipients of 20 ×  106 cells. Although, as also noted above,  12 
of 18  (67%)  large  Lew/BN  grafts survived  for >100  d  on  these  hosts,  only 3  of 25 
(12%)  small Lew/BN grafts were not rejected  (P <  0.01). 
Survival of First and Second Large BN or Lew/  BN Grafts on Putatively  Tolerant Hosts.  To 
determine  how  rats  that  accepted  or  rejected  large  Lew/BN  or  BN  skin  grafts 
responded to second large Lew/BN or BN grafts, they were either regrafted when the SILVERS  ET AL.  593 
TABLE  I 
Survival of Large * and Small~ BN or Lew/BN Skin Grafts on Lew Rats Inoculated at Birth with 
Lew/BN Bone Marrow Cells 
Number of 
cells inocu-  Number of  Graft size Graft donor  lated  hosts 
(x lO  ~) 
100  Large  BN  20 
Lew/BN  19 
Small  BN  16 
Lew/BN  17 
20  Large  BN  19 
10  Large 
Lew/BN  18 
Small  BN  41 
Lew/BN  25 
BN  16 
Lew/BN  15 
Survival times  MST§ 
d 
12, 13,11 2 x  24,11 42,[1 70,11 14 x  >100  >100 
40, 18 × >100  >100 
13, 15, 21, 22, 25, 2 × 26, 29, 34, 2 ×  35,  >29.3 
40, 42, 47, 75, 97 
22, 29, 61, 14 × >100  >100 
9,2×  10,2×  11,2×13,18,21,2×22,  >23.4 
26, 2 × 53, 84, 92, 3 × >100 
11, 21, 23, 35, 71, 72, 12 x  >100  >100 
4x9,6x  lO, 3x  12,3x  13,2x  14, 15,  >16.6 
17, 2 ×  18, 19, 20, 21, 3 x  22, 2 x  25, 
26, 2 × 28, 30, 32, 33, 2 x  34, 37, 42, 
>100 
6 x  9, 2 ×  12, 14, 15, 2 × 22, 2 × 26, 27,  >19.5 
30, 3l, 33, 35, 2 × 36, 97, 3 × >100 
4 × 9, 3 ×  10, 1l, 7 ×  12, 18  10.3 
4 x  9, 10, 11, 3 ×  12, 13, 14, 15, 2 × 22,  11.4 
26 
* From 4.0 to 6.25 cm  2. 
From 0.75 to 1.5 cm  2. 
§ In calculating the MST, grafts that were not rejected were scored as surviving for 100 d. 
II These grafts were scored as rejected on the day noted. However, subsequently some pigmented hairs were 
observed emerging from the scar tissue which formed. 
initial graft  had been in residence for  100 d, or 4-6 wk after the first graft had been 
rejected. The results (Table II) to a  large degree depended upon the number  of cells 
used  to induce tolerance.  When  unresponsiveness was  induced with  100  ×  106 cells, 
all animals that had accepted initial grafts, regardless of their origin, accepted second 
grafts. This was even the case for the five animals regrafted with Lew/BN  skin whose 
initial BN  grafts  were  recognized only by the persistence of a  few  pigmented hairs. 
Indeed, when three  of these  animals were  subsequently grafted  a  third  time with  a 
second large BN graft, although the grafts were partially rejected,  they all recovered 
and eventually attained almost their original size. 
On  the  other  hand,  the  response  of Lew  rats  inoculated  with  20  ×  106  cells  to 
second  grafts  was  much  more  variable.  Although  second  grafts  on  rats  that  had 
rejected first grafts usually were rejected acutely, there were two exceptions. One rat 
rejected  its  initial BN  graft  in  18  d  yet  accepted  a  second  Lew/BN  graft  for  72  d; 
another  similarly treated  animal accepted  a  second  BN  graft  for  53  d  after  having 
accepted  its initial BN graft  for only 26 d. Another observation unique to this panel 
of hosts was the deleterious influence second grafts sometimes had on the survival of 
first  transplants.  6  of  14  animals bearing flourishing first  grafts  rejected  both  grafts 
within 15 d  of being regrafted. In fact, in only three animals were we unable to detect 
an immune response against either graft. 
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TABLE  II 
Survival of First and Second Large * BN or Lew/BN Skin Grafts on Lew Rats Inoculated at Birth with 
Lew/BN Bone Marrow Cells 
Number 
of cells in-  Second  Number of 
oculated  First graft  graft~  hosts 
(x lo  ~) 
Survival first graft/survival second graft 
100 
20 
BN  Lew/BN  l 6 
Lew/BN  BN  13 
BN  BN  4 
Lew/BN  Lew/BN  5 
BN  Lew/BN  11 
Lew/B  N  B N  12 
BN  BN  6 
Lew/BN  Lew/BN  6 
d 
12/11,  13§/>100,1[,  2 X 24§/>10011 , 42{]/>100,  70{}/ 
>100,  10 x  >200/>100 
13 ×  >200/>100 
4 ×  >200/>100 
5 ×  >200/>100 
9/8,  10/8,  t 1/8, 13/8,  18/72, 2 X 22/8, 84/10, 92/ 
10,  l t5/15, >200/>100 
35/9,  71/9, 72/9,  109/9,  110/9,  112/9,  112/10, 
>200/9,¶, 3 x  >200/>100,** >200/2~I00 
11/9,  13/9, 21/14, 26/53, 2 ×  53/9 
11/8, 21/8, 23/8,  110/9, >200/>100,** >200/>100 
* From 4.0 to 6.25 cm  z. 
:~ Recipients challenged with second grafts 4-6 wk after first graft scored as rejected or after first graft had 
survived for 100 d. 
§ These grafts were scored as rejected on the day noted, ttowever, subsequently some pigmented hairs 
were observed emerging from the scar tissue that formed. 
[I These animals were also subsequently challenged with a second BN graft and although these grafts were 
partially rejected they recovered, attained almost their original size (with numerous hairs) and survived 
for >100 d. 
¶ This graft was scored as rejected on the day noted. However, subsequently a few pigmented hairs were 
observed emerging from the scar tissue that formed. 
** These grafts were partially rejected but recovered and eventually attained -50% of their original size. 
TABLE  III 
Survival of Small*  BN and Lew/BN Skin Grafts  Transplanted  Simultaneously  to Lew Rats Inoculated at 
Birth with Lew/BN Bone Marrow Cells 
Number of  Number of 
cells inocu-  hosts  Survival BN graft/survival Lew/BN graft 
lated (×  10  ~) 
100  26 
20  20 
d 
11/11,14/14,28/28,28/36,65/65,72/72,82/69,89/82,2  X 97/>100,98/ 
98,>100/89,  >100/97,  13 X >100/>100 
11/13,  11/14, 21/22, 22/22, 23/23, 27/28, 27/30, 30/34, 2 x  31/31, >32/ 
>32,~ 36/36, >36/>36,~ 42/42, 63/63,  70/71, 97/97,98/98,  2 X >100/ 
>100 
* From 0.75  to 1.5 cm  2. 
:~ Animal died. 
was  a  discrepancy  in  the  survivals  of  BN  and  Lew/BN  grafts  when  transplanted 
separately,  their fates were determined  when  transplanted  to  the same  host.  Accord- 
ingly,  Lew  rats  that  had  been  inoculated  at  birth  with  20  or  100  ×  106  cells  were 
grafted  with  a  small  BN  graft  on  one side of their  thorax  and  with  a  similarly  sized 
Lew/BN  graft on the other. The  results (Table III) indicate  that although  concomitant 
exposure  to  both  grafts  had  no  significant  effect  on  the  survival  of  the  F1  hybrid 
transplants,  i.e.,  their survivals  were  similar  to  those  grafted  alone,  it  promoted  the SILVERS  ET AL.  595 
TABLE IV 
Survival of Small* and Large~ Lew/BN Skin Grafts Transplanted 
Simultaneously to Lew Rats Inoculated at Birth with 20 ×  106 Lew/BN 
Bone Marrow Cells 
Number of  Survival small graft/survival large graft  hosts 
d 
16  10/10,  14/14,  18/18, 27/27, 31/33, 11 × >100/>100 
* From 0.8 to 1.5 cm  2. 
:1: From 4.0 to 6.25 cm  2. 
TABLE  V 
Survival of Small* BN and Large~ Lew/BN Skin Grafts Transplanted 
Simultaneously to Lew Rats Inoculated at Birth with 20 ×  106 Lew/BN 
Bone Marrow Cells 
Number of  Survival small BN graft/survival large Lew/BN graft  hosts 
d 
21  2 × 9/9, 9/11, 12/12,  18/18, 25/26, 26/26, 27/27, 35/36, 
39/>100, :>43/>43,§ >50/>50,§ 9 × >100/>100 
* From 0.8 to 1.5 cm  2. 
:~ From 4.0 to 6.25 cm  ~. 
§ Animal died. 
TAaLE  VI 
Survival of First Small* BN and Second Large  ~ Lew/BN Skin Grafts on Lew Rats 
Inoculated at Birth with 20 ×  106 Lew/BN Bone Marrow Cells 
Number of  Survival small BN graft/survival large Lew/BN graft§  MST  hosts 
d 
19  2 X 9/8, 9/9, 10/8,  10/11,  11/18, 13/8,  14/8,  14/9,  15.7/10.4 
17/19, 18/10,  19/12, 21/14, 28/10, 32/12, 33/15, 
34/13, 34/15, 37/18 
* From 0.75 to 1.5 cm  2. 
~c From 4.0 to 6.25 cm  ~. 
§ Recipients challenged with large Lew/BN graft 2-22 d after small BN graft scored 
as rejected. 
survival of the BN grafts. This was especially seen in recipients that had received  100 
X  106 cells. Whereas  16 such hosts all rejected small single BN grafts  (see Table I),  15 
of 26  (58%)  of these grafts survived for >100 d  when accompanied by an Fx hybrid 
transplant.  Recipients of 20  ×  106 cells also accepted  BN  grafts  more  readily when 
they were accompanied by Lew/BN  transplants. Thus, if one defines animals accept- 
ing their test  graft  for at  least  14  d,  i.e., >3  SD  in excess of the MST  on untreated 
hosts,  as  tolerant  (1),  18  of 20  (90%)  recipients of 20  ×  106  cells  that  were  grafted 
bilaterally displayed some level of tolerance of the small BN graft, compared with 25 
of 41  (61%)  rats challenged with the BN graft alone (P <  0.05). 
It also should be noted that when both BN and Lew/BN  grafts were rejected, there 
was  usually no more  than  a  few  days  difference  in  their  survivals, and  in  the  few 596  SURVIVAL OF SKINGRAFTS  ON TOLERANT  RATS 
animals  (all  100  ×  106 cell recipients)  in which  this was not  the case,  neither  graft 
appeared to be favored. 
Survival of Large and Small  Grafts Transplanted to the Same Host.  If the  relationship 
between graft size and graft acceptance is solely a  function of antigen  dosage, then 
small grafts should fare as well as large ones when both are transplanted to the same 
putatively tolerant  hosts.  To determine whether this is the case, panels of Lew rats 
that had received 20 ×  106 Lew/BN cells were challenged with a large F1 hybrid graft 
on one side of their thorax and with either a small BN or F1 hybrid graft on the other. 
The results (Tables IV and V) are in accord with the contention that the amount of 
antigen the host is challenged with rather than the size of the grafts per se determine 
their  fate. Whereas  only 3  of 25  (12%)  small  Lew/BN  and  1 of 41  (2%)  small  BN 
grafts survived for >100 d when grafted alone (see Table I), 11 of 16  (69%)  and 9 of 
19  (47%)  of these grafts, respectively, survived for >100  d  when transplanted  along 
with large F1 hybrid grafts (P <  0.01).  Indeed, with one exception (see Table V), the 
small  grafts survived  as  well  as  the  large  grafts.  On  the  other  hand,  concomitant 
exposure to both grafts had no significant effect on the survival of the large grafts. 
Survival of LaNe Grafts on Rats That Have Rejected Small Grafts.  Although  the above 
results demonstrate that the survival of skin grafts on putatively tolerant hosts depends 
upon their size (amount of antigen) and genotype (homozygous or heterozygous), they 
do  not  provide  any  definitive  information  as  to  why  these  factors  are  important. 
Accordingly, the last experiment addressed this question. In this experiment,  19 Lew 
recipients of 20 ×  106 cells that had rejected small BN grafts were regrafted with large 
Lew/BN  transplants.  It was reasoned  that  inasmuch  as >60%  of these  large grafts 
were accepted when transplanted  to previously ungrafted but similarly treated Lew 
recipients (see Table I), they should  also be accepted by a  similar proportion of the 
previously grafted animals unless exposure to the first grafts had altered their immune 
response. As indicated in Table VI, all the second grafts were rejected within  19 d. 
Discussion 
These results demonstrate that  the attributes of the test grafts putatively tolerant 
rats  are  challenged  with  influence  their  immune  response.  Large  grafts  are  more 
readily accepted than small grafts and F1 hybrid grafts survive better than homozygous 
parental strain allografts. Indeed, the behavior of MHC-incompatible skin grafts on 
putatively tolerant  rats bears a  striking similarity to the behavior of grafts that are 
only incompatible with respect  to weak transplantation  antigens  (8,  9).  When  only 
weak histoincompatibilities prevail, there is also a  direct  relationship between graft 
size and graft survival (10,  1 l) as well as evidence for a gene dosage effect (12). There 
are  other  analogies,  too.  Tolerant  rats  that  accept  first  MHC-incompatible  grafts 
usually accept second grafts and the same applies to female rats that have accepted 
male skin isografts, i.e., grafts incompatible only with respect to the weak H-Y antigen 
(11,  13). Moreover,  in  both  instances  animals  that  have  manifested  an  immune 
response usually reject subsequent grafts in an accelerated fashion, regardless of their 
size (11,  13). Still another similarity is the manner in which putatively tolerant rats 
and those challenged with H-Y-incompatible skin respond to small and large grafts 
transplanted  simultaneously.  In  both  situations  the  total  amount  of incompatible 
skin, rather than  the size of each graft, appears to be the most important  factor in 
determining their fate (11). SILVERS ET AL.  597 
In retrospect, failure to recognize the key role that test grafts play in the immune 
response of neonatally treated rats is not surprising because, when tolerance was first 
discovered, it was believed to result solely from the specific elimination of clones of 
cells that normally mediate rejection (14,  15). Although there are situations in accord 
with  this explanation  (16,  17)  and,  in  fact, in such cases the attributes of the graft 
would not be expected to influence its survival, we now know that most instances of 
tolerance represent a  heterogeneous state involving not only the specific elimination 
of cells potentially harmful  to the graft but  also  their proliferation,  the activity of 
suppressor cells, and perhaps the participation of blocking serum factors as well (18- 
25).  Indeed, when one looks at tolerance as the outcome of all of these mechanisms, 
it is not at all surprising that the attributes of the graft can either foster its induction 
or influence the response of the host in favor of immunity. 
If one assumes that  the primary difference between MHC  and non-MHC  trans- 
plantation barriers is the number of cells available to react with the graft, elimination 
of some of these cells in MHC-incompatible situations, as would be expected to occur 
after neonatal exposure of Lew rats to Lew/BN bone marrow cells, could make them 
comparable. In fact, if the degree of clonal deletion is directly related to the number 
of cells  inoculated  at  birth,  one might  expect  test  grafts to have a  more profound 
influence on the immune state of Lew rats inoculated with  20 ×  106 than with  100 
×  106 F1 hybrid cells. This seems to be the case. Whereas after the inoculation of 100 
×  106 cells all rats that accepted large Lew/BN or BN grafts for 100 d  subsequently 
accepted second large Lew/BN or BN grafts, ~40% of the 20 ×  106 cell recipients that 
accepted their initial  grafts for  100  d  rejected these grafts, as well as second grafts, 
within  15 d of regrafting. 
It also should  be noted that because rats challenged with both BN and Lew/BN 
grafts are exposed to considerably more antigen than recipients of single small grafts, 
it  is difficult  to assess what  influence the genotypes of the two grafts have on their 
survival. Moreover, because Lew/BN grafts fare better than similarly sized BN grafts, 
the relationship between graft size and graft dosage cannot be attributed simply to 
the availability of more antigen. Indeed, the better survival of Fx hybrid skin grafts on 
putatively tolerant  Lew rats could be related to the ease with which  the survival of 
Lew/BN but not BN kidneys are immunologically enhanced in Lew adults  (26). 
Finally, the possible involvement of skin-specific antigens should not be overlooked. 
Such  antigens  are known  to occur in  mice (27,  28)  and could explain many of the 
results reported here. 
Summary 
The attributes of the test grafts with which putatively tolerant rats are challenged 
influence their immune response. Lewis (Lew) rats inoculated at birth with Lew/BN 
Fa  hybrid  bone  marrow cells  accept  large  skin  allografts  more  readily  than  small 
allografts, and Fa hybrid skin grafts survive better than BN transplants.  The results 
indicate  that  the survivals of these  major histocompatibility complex-incompatible 
grafts are determined by the same factors that operate when only weak histoincom- 
patibilities prevail. 
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